{{Rsnum
|rsid=3769671
|Gene=POMC
|Chromosome=2
|position=25167284
|Orientation=plus
|GMAF=0.04454
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=POMC
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 90.8 | 9.2 | 0.0
| HCB | 88.9 | 11.1 | 0.0
| JPT | 95.5 | 4.5 | 0.0
| YRI | 95.2 | 4.8 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 88.9 | 11.1 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21723177
|Title=Association analysis of proopiomelanocortin (POMC) haplotypes in type 1 diabetes in a UK population
}}{{PMID Auto
|PMID=18589403
|Title=The opioid peptides enkephalin and beta-endorphin in alcohol dependence.
|OA=1
}}

{{PMID Auto
|PMID=19217079
|Title=Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies.
|OA=1
}}

{{PMID Auto
|PMID=19723618
|Title=Genetic variation in the hypothalamic-pituitary-adrenal stress axis influences susceptibility to musculoskeletal pain: results from the EPIFUND study.
|OA=1
}}